Content
60%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A rigorously structured research pipeline with concrete scripts, explicit validation phases, and a well-signaled one-level-deep reference bundle. Its main problems are redundancy — the enterprise dimensions and E3-E7 workflow each appear multiple times — and long inlined contract paragraphs that duplicate reference files and inflate the always-loaded body.
Suggestions
State the six enterprise dimensions once (keep the E1-E7 checklist) and have 'Enterprise Research Integration', 'Six-Dimension Collection', and the duplicate 'E3-E7' section point to enterprise_research_methodology.md instead of re-listing them.
Compress the 'Run and asset contract' and P1 continuation paragraphs into a short mandate plus pointers to research-asset-contract.md and provider-run-contract.md, which already contain the detailed rules.
Use the full references/ path consistently (e.g. replace bare 'enterprise_quality_checklist.md' citations) so every reference resolves unambiguously.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The six enterprise dimensions are listed three times ("Enterprise Workflow Overview" D1-D6, "Enterprise Research Integration" Tasks A-F, and "Six-Dimension Collection"), E3-E5 are described twice in conflicting sections ("E3: Select Analysis Frameworks Only When Useful" vs. the later "E3-E7" block), and the dense "Run and asset contract" paragraphs restate rules that live in research-asset-contract.md and provider-run-contract.md. This is noticeably verbose with several duplicated/padded sections, though it avoids explaining concepts Claude already knows (so not 1). | 2 / 5 |
Actionability | Concrete commands appear throughout: "run `provider_runs.py plan`", "run `provider_runs.py validate`, `research_assets.py check`, and register the study", exact status formats ("[P0 complete] Subagent: {yes/no}. Mode: {standard/lightweight}. AS_OF: {YYYY-MM-DD}."), and a full registry output template. Not 5 because script invocations lack complete argument examples and some guidance stays abstract ("Assign one owner per control surface and serialize that owner's UI actions"); not 3 because the guidance is mostly concrete and directly executable. | 4 / 5 |
Workflow Clarity | The P0-P7 pipeline is clearly sequenced with per-phase status reports, an explicit mandatory validation phase ("P6: Counter-Review (Mandatory)" with the five opposite-view checks), L1/L2/L3 quality gates, and a final verification checklist in P7. Not 5 because the enterprise path is presented twice with overlapping and differently-framed E3-E7 sections, which muddies the sequence a reader should follow; not 3 because validation checkpoints are explicit and plentiful, not merely implicit. | 4 / 5 |
Progressive Disclosure | Reference tables with "When to Load" columns clearly signal all 18 reference files and 3 scripts (each verified to exist in the bundle), and references are one level deep. Not 5 because the body inlines substantial contract detail that duplicates the references (the asset/provider-run paragraphs) and two citations use a bare filename without the references/ path ("see enterprise_quality_checklist.md"); not 3 because most content is appropriately placed with explicit load triggers. | 4 / 5 |
Total | 14 / 20 Passed |